Iqvia Holdings (IQV) Cash & Equivalents (2011 - 2026)
Iqvia Holdings (IQV) posted Cash & Equivalents of $1.9 billion for Q2 2026, down 1.95% sequentially from $1.9 billion in Q1 2026, and down 6.38% YoY from $2.0 billion in Q2 2025.
Iqvia Holdings (IQV) Cash & Equivalents (2011 - 2026) Analysis & Trends
Iqvia Holdings has reported Cash & Equivalents for 16 years, with the latest figure at $1.9 billion in Q2 2026.
- Quarterly Cash & Equivalents fell 6.38% year-over-year to $1.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.9 billion (down 6.38% YoY) and the FY2025 annual result came in at $2.0 billion, up 16.33% from the prior year.
- Cash & Equivalents fell to $1.9 billion in Q2 2026 per IQV's latest filing, from $1.9 billion in the prior quarter.
- Over five years, Cash & Equivalents peaked at $2.0 billion in Q2 2025 and troughed at $1.2 billion in Q4 2022.
- A 5-year average of $1.6 billion and a median of $1.5 billion in 2023 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2022 and 2025: Cash & Equivalents slumped 39.83% in 2022, then soared 31.97% in 2025.
- Over 5 years, Cash & Equivalents stood at $1.2 billion in 2022, then advanced by 13.16% to $1.4 billion in 2023, then advanced by 23.69% to $1.7 billion in 2024, then climbed by 16.33% to $2.0 billion in 2025, then retreated by 3.59% to $1.9 billion in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $1.9 billion, $1.9 billion, and $2.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 4.06 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 4.35 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 1.10 Bn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 1.81 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 1.91 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 196.93 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 1.04 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 51.40 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 141.80 Mn |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn | 626.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.91 Bn |
| Mar 31, 2026 | 1.95 Bn |
| Dec 31, 2025 | 1.98 Bn |
| Sep 30, 2025 | 1.81 Bn |
| Jun 30, 2025 | 2.04 Bn |
| Mar 31, 2025 | 1.74 Bn |
| Dec 31, 2024 | 1.70 Bn |
| Sep 30, 2024 | 1.57 Bn |
| Jun 30, 2024 | 1.55 Bn |
| Mar 31, 2024 | 1.44 Bn |
| Dec 31, 2023 | 1.38 Bn |
| Sep 30, 2023 | 1.22 Bn |
| Jun 30, 2023 | 1.38 Bn |
| Mar 31, 2023 | 1.49 Bn |
| Dec 31, 2022 | 1.22 Bn |
| Sep 30, 2022 | 1.27 Bn |
| Jun 30, 2022 | 1.43 Bn |
| Mar 31, 2022 | 1.39 Bn |
| Dec 31, 2021 | 1.37 Bn |
| Sep 30, 2021 | 1.47 Bn |